Evidence map›Paper›PMID 26324178›Full record

ArticleScientific reports2015

Octanoylation of early intermediates of mycobacterial methylglucose lipopolysaccharides.

Ana Maranha, Patrick J Moynihan, Vanessa Miranda, Eva Correia Lourenço, Daniela Nunes-Costa, Joana S Fraga, Pedro José Barbosa Pereira, Sandra Macedo-Ribeiro, M Rita Ventura, Anthony J Clarke and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. International journal of molecular sciences · 2022
    Article
  4. Article
  5. TheThe Biochemical journal · 2019
    Review
  6. Article
  7. Distribution of glucan-branching enzymes among prokaryotes.Cellular and molecular life sciences : CMLS · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ana MaranhaCNC - Center for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal.
Patrick J MoynihanDepartment of Molecular and Cellular Biology, University of Guelph, Ontario, Canada.
Vanessa MirandaITQB - Instituto de Tecnologia Química Biológica, Universidade Nova de Lisboa, Portugal.
Eva Correia LourençoITQB - Instituto de Tecnologia Química Biológica, Universidade Nova de Lisboa, Portugal.
Daniela Nunes-CostaCNC - Center for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal.
Joana S FragaIBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Portugal.
Pedro José Barbosa PereiraIBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Portugal.
Sandra Macedo-RibeiroIBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Portugal.
M Rita VenturaITQB - Instituto de Tecnologia Química Biológica, Universidade Nova de Lisboa, Portugal.
Anthony J ClarkeDepartment of Molecular and Cellular Biology, University of Guelph, Ontario, Canada.
Nuno EmpadinhasCNC - Center for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycobacteria synthesize unique intracellular methylglucose lipopolysaccharides (MGLP) proposed to modulate fatty acid metabolism. In addition to the partial esterification of glucose or methylglucose units with short-chain fatty acids, octanoate was invariably detected on the MGLP reducing end. We have identified a novel sugar octanoyltransferase (OctT) that efficiently transfers octanoate to glucosylglycerate (GG) and diglucosylglycerate (DGG), the earliest intermediates in MGLP biosynthesis. Enzymatic studies, synthetic chemistry, NMR spectroscopy and mass spectrometry approaches suggest that, in contrast to the prevailing consensus, octanoate is not esterified to the primary hydroxyl group of glycerate but instead to the C6 OH of the second glucose in DGG. These observations raise important new questions about the MGLP reducing end architecture and about subsequent biosynthetic steps. Functional characterization of this unique octanoyltransferase, whose gene has been proposed to be essential for M. tuberculosis growth, adds new insights into a vital mycobacterial pathway, which may inspire new drug discovery strategies.

Indexed as

Bacterial ProteinsFatty AcidsGlycosylationGlycosyltransferasesKineticsLipopolysaccharidesMagnetic Resonance SpectroscopyMass SpectrometryMycobacteriumRecombinant ProteinsSubstrate SpecificityBacterial ProteinsFatty AcidsGlycosyltransferasesLipopolysaccharidesRecombinant Proteins

Identifiers

PMID26324178
PMCPMC4555173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.